Jeffrey P. Whitten
78 works · 2,888 citations · h-index 25
Top works
- Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues
- Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis
- Design and Synthesis of a Series of Non-Peptide High-Affinity Human Corticotropin-Releasing Factor1 Receptor Antagonists
- A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages
- Rapid Microscale Synthesis, a New Method for Lead Optimization Using Robotics and Solution Phase Chemistry: Application to the Synthesis and Optimization of Corticotropin-Releasing Factor1Receptor Antagonists
- [2-(Trimethylsilyl)ethoxy]methyl (SEM) as a novel and effective imidazole and fused aromatic imidazole protecting group
- Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
- NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations
- Diphenyl 2-pyridylphosphine and di-tert-butylazodicarboxylate:Convenient reagents for the Mitsunobu reaction
- (S)-(−)-5-Ethynyl-3-(1-methyl-2-pyrroli- dinyl)pyridine Maleate (SIB-1508Y): A Novel Anti-Parkinsonian Agent with Selectivity for Neuronal Nicotinic Acetylcholine Receptors
- A facile synthesis of aromatic trifluoromethyl compounds via orthothio esters
- Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis
- A convenient synthetic access to β, β-difluoro-γ-keto-α-amino acids. Application to the synthesis of a potential inhibitor of kynureninase
- (R)-4-Oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex
- Total synthesis of psorospermin
- Synthesis and cardiotonic activity of novel biimidazoles
- A convenient procedure for the preparation of 4(5)-cyanoimidazoles
- Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics
- Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer
- Conformationally restricted analogues of nicotine and anabasine